Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
GB241
Rituximab
Locations
1
China
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Start Date
June 5, 2017
Primary Completion Date
May 20, 2019
Completion Date
May 20, 2019
Last Updated
March 23, 2021
NCT05139017
NCT06026319
NCT01804686
NCT05442515
NCT06045247
NCT05755087
Lead Sponsor
Nanjing Yoko Biomedical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions